The Russell H. Morgan Department of Radiology and Radiological Sciences, the Johns Hopkins Medical Institutions, 600 N Wolfe St, Phipps B-112, Baltimore, MD 21287, USA.
Radiology. 2010 Apr;255(1):135-41. doi: 10.1148/radiol.09090831.
To assess the patient care benefit of a recently implemented institutional policy requiring official second-opinion consultation for all studies performed outside the institution.
The institutional review board approved the retrospective review of patient data for this HIPAA-compliant study and waived the need for individual informed consent. The second-opinion consultation reports for outside neuroradiology studies finalized by subspecialty-trained neuroradiologists within calendar year 2008 were compared with the outside reports provided with the images. The reports were categorized by using a five-point scale: 1 indicated no difference in interpretation; 2, clinically unimportant difference in detection; 3, clinically unimportant difference in interpretation; 4, clinically important difference in detection; and 5, clinically important difference in interpretation. Clinically important differences were defined as those likely to change patient care or diagnoses. Statistical comparisons were performed by using two-sample continuity-corrected Z tests with two-sided alternatives. Bonferroni corrections were performed when more than two rates were compared. Confidence intervals for all rates were constructed by using the score interval along with the Yates continuity correction.
Of 7465 studies, 4534 (60.7%) had an outside report for comparison. There were 347 (7.7%) instances with clinically important differences. Of these 347 discrepancies, 233 (67.1%) were category 4 and 114 (32.9%) were category 5. When the final diagnosis was determined from pathology reports, clinical assessments, and/or imaging follow-up, the second-opinion consultation was noted to be correct in 163 (84.0%) of 194 studies with category 4 or 5 discrepancies.
A 7.7% rate of discrepant interpretations (347 of 4534 studies) was noted for a service offering second-opinion consultations for outside examinations. Most were discrepancies in detecting abnormalities rather than in interpreting identified findings. When a definitive diagnosis was obtainable, the second-opinion consultation was more accurate in 84% of studies. Review of outside studies benefits patient care.
评估最近实施的一项机构政策对所有机构外进行的检查进行正式的二次会诊的患者护理效益。
机构审查委员会批准了这项符合 HIPAA 规定的回顾性研究患者数据的回顾,并免除了对个人知情同意的需要。在 2008 年内由神经放射学专家对外部神经放射学检查的二次会诊报告进行最终审核,并将其与图像一起提供的外部报告进行比较。报告根据五分制进行分类:1 表示解释上无差异;2,表示检测上有临床意义不大的差异;3,表示解释上有临床意义不大的差异;4,表示检测上有临床意义重要的差异;5,表示解释上有临床意义重要的差异。临床意义重要的差异定义为可能改变患者护理或诊断的差异。通过使用双边替代的两样本连续校正 Z 检验进行统计比较。当比较两个以上的率时,进行 Bonferroni 校正。所有率的置信区间均通过分数区间和 Yates 连续性校正来构建。
在 7465 项研究中,有 4534 项(60.7%)有外部报告进行比较。有 347 项(7.7%)存在临床意义重要的差异。在这 347 个差异中,有 233 项(67.1%)为 4 类,114 项(32.9%)为 5 类。当最终诊断是根据病理报告、临床评估和/或影像学随访确定的,在有 4 类或 5 类差异的 194 项研究中,二次会诊被认为是正确的有 163 项(84.0%)。
对于提供外部检查二次会诊的服务,发现了 7.7%(4534 项研究中有 347 项)的解释差异。大多数差异是在检测异常而不是在解释已识别的发现方面。当可以获得明确的诊断时,二次会诊在 84%的研究中更准确。对外部研究的审查有益于患者护理。